I didn't get to see much the final day of ASMS as I traveled back, but the two of us from our group who got to go are working on a wrapup for those who couldn't. It'll honestly take months for me to sort through all the notes and for the Google Scholar alerts to stop coming in for all the cool stuff I don't feel I can't talk about yet.
My biggest takeaway --
Our field is still beset with difficulties -- but the instruments don't seem to be the problem right now. How can it be with so many people achieving near theoretical proteomic coverage? With thousands of PTMs of any type seeming like something that even I could get?
This ASMS felt like -- time to confront our biggest shortcomings, like:
1) The fact proteins are really hard to get out of cells easily and consistently
There were sample prep robots everywhere! And high tech new sample prep kits, like S-Trap, the awesome thing Pitt is working on that I can't find note of yet, some new stuff coming from vendors themselves (finally?) that all seem tilted toward being automation compatible
2) The big one -- How immature our informatics are -- and how we fix it!
I think I'd been lulled into some sort of a complacency finally that our data processing pipelines are just fine. A major emphasis of ASMS on the proteomics end is that they aren't. They're better than they have ever been, but this explosion in scan speed and data complexity is showing that some of our core early 2000s data processing assumptions are in serious need of updates -- but really really smart people are working on it. We probably don't ever need to get as sophisticated as the genomics people -- our raw instrument output is easily 1,000 times less noisy and more accurate than theirs (have you looked at raw output from these next gen things?!?) but we've got some ground to make up.
(Another way to make myself feel better, I went to some metabolomics talks -- they're trying hard and making up ground, but they are way behind where we are, partially due to the smaller size of their field, some really poor assumptions that were made in the past, and --most importantly -- some really unique problems they face. "Oh-- cis- and trans- makes a huge difference here? Great! Best of luck with that! I'll...umm...check..back...later...")
3) Glycomics and glycoproteomics are coming -- and is about to become a primary thing we hear about. I'd have to stop and check the signs while walking around "yup -- I'm still surrounded by posters about sugars..." Everything is glycosylated -- and glycans totally suck to work with -- but it wouldn't be crazy to suggest that they are more phenotypically important than unmodified proteins.
New reagents, new columns, new methods, new software. It's all going to help when that scientist knocks on your door and has no intention of letting you cleave the sugars off and throw them into the waste bin. "Oh -- d- and l- makes a huge difference here? I'll...umm....")
4) Proteogenomics may finally be something that I can do! Surely, out of all of these new tools there has got to be at least one -- at least one -- that I'm smart enough to figure out how to use, right? I hope more details to be on the way soon!